BioAge Labs Inc’s filing revealed that its Director Pande Vijay Satyanand acquired Company’s shares for reported $2.5 million on Oct 01 ’24. In the deal valued at $19.73 per share,126,793 shares were bought. As a result of this transaction, Pande Vijay Satyanand now holds 1,026,793 shares worth roughly $20.63 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Pande Vijay Satyanand bought 67,096 shares, generating $1,323,804 in total proceeds. Upon buying the shares at $19.73, the Director now owns 1,093,889 shares.
Before that, Pande Vijay Satyanand bought 25,306 shares. BioAge Labs Inc shares valued at $503,589 were divested by the Director at a price of $19.90 per share. As a result of the transaction, Pande Vijay Satyanand now holds 1,119,195 shares, worth roughly $22.48 million.
Morgan Stanley initiated its BioAge Labs Inc [BIOA] rating to an Overweight in a research note published on October 21, 2024; the price target was $40. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Citigroup began covering BIOA with “Buy” recommendation on October 21, 2024.
Price Performance Review of BIOA
On Friday, BioAge Labs Inc [NASDAQ:BIOA] saw its stock jump 9.36% to $20.09. Over the last five days, the stock has gained 6.86%. BioAge Labs Inc shares have risen nearly 9.72% since the year began.
Levels Of Support And Resistance For BIOA Stock
The 24-hour chart illustrates a support level at 18.97, which if violated will result in even more drops to 17.85. On the upside, there is a resistance level at 20.79. A further resistance level may holdings at 21.49. The Relative Strength Index (RSI) on the 14-day chart is 52.41, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.18, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 6.88%. Stochastics %K at 60.83% indicates the stock is a holding.
How much short interest is there in BioAge Labs Inc?
A steep rise in short interest was recorded in BioAge Labs Inc stocks on 2024-11-15, growing by 1.4 million shares to a total of 2.37 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 0.97 million shares. There was a rise of 58.98%, which implies that there is a positive sentiment for the stock.
